Robert G. Ridley

Haemozoin formation in malaria parasites: is there a haem polymerase?

R. Ridley, Robert G. Ridley, 1996, Trends in microbiology.

An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials.

H. Matile, J. Vennerstrom, A. Dorn, 1998, Biochemical pharmacology.

Expression and characterisation of plasmepsin I from Plasmodium falciparum.

U. Certa, B. Dunn, J. Kay, 1997, European journal of biochemistry.

Antimalarial activity of the bisquinoline trans-N1,N2-bis (7-chloroquinolin-4-yl)cyclohexane-1,2-diamine: comparison of two stereoisomers and detailed evaluation of the S,S enantiomer, Ro 47-7737

F. Theil, H. Matile, A. Guenzi, 1997, Antimicrobial agents and chemotherapy.

Naturally‐occurring and recombinant forms of the aspartic proteinases plasmepsins I and II from the human malaria parasite Plasmodium f alciparum

I. Gluzman, D. Goldberg, J. Kay, 1999, FEBS letters.

Plasmodium: drug discovery and development--an industrial perspective.

R. Ridley, Robert G. Ridley, 1997, Experimental parasitology.

A comparison and analysis of several ways to promote haematin (haem) polymerisation and an assessment of its initiation in vitro.

H. Matile, J. Vennerstrom, A. Dorn, 1998, Biochemical pharmacology.

Studies on plasmepsins I and II from the malarial parasite Plasmodium falciparum and their exploitation as drug targets.

U. Certa, J. Kay, A. D'arcy, 1998, Advances in experimental medicine and biology.